Skip to main content
SpringerLink
Log in

Protective Effect of Seleno-l-Methionine on Cyclophosphamide-Induced Urinary Bladder Toxicity in Rats

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Cyclophosphamide (CP) is a widely used antineoplastic drug, which could cause toxicity of the normal cells due to its toxic metabolites. Its urotoxicity may cause dose-limiting side effects like hemorrhagic cystitis. Overproduction of reactive oxygen species (ROS) during inflammation is one of the reasons of the urothelial injury. Selenoproteins play crucial roles in regulating ROS and redox status in nearly all tissues; therefore, in this study, the urotoxicity of CP and the possible protective effects of seleno-l-methionine (SLM) on urinary bladder of rats were investigated. Intraperitoneal (i.p.) administration of 50, 100, or 150 mg/kg CP induced cystitis, in a dose-dependent manner, as manifested by marked congestion, edema and extravasation in rat urinary bladder, a marked desquamative damage to the urothelium, severe inflammation in the lamina propria, focal erosions, and polymorphonuclear (PMN) leukocytes associated with occasional lymphocyte infiltration determined by macroscopic and histopathological examination. In rat urinary bladder tissue, a significant decrease in the endogenous antioxidant compound glutathione, and elevation of lipid peroxidation were also noted. Pretreatment with SLM (0.5 or 1 mg/kg) produced a significant decrease in the bladder edema and caused a marked decrease in vascular congestion and hemorrhage and a profound improvement in the histological structure. Moreover, SLM pretreatment decreased lipid peroxide significantly in urinary bladder tissue, and glutathione content was greatly restored. These results suggest that SLM offers protective effects against CP-induced urinary bladder toxicity and could be used as a protective agent against the drug toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Selvakumar E, Prahalathan C, Sudharsan PT, Varalakshmi P (2006) Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm. Toxicology 217:71–78

    Article  CAS  PubMed  Google Scholar 

  2. Alfieri B, Gardner CJ (1997) The NK1 antagonist, GR203040, inhibits cyclophosphamide-induced damage in the rat and ferret bladder. Br J Pharmacol 29:245–250

    CAS  Google Scholar 

  3. Frasier LU, Sarathchandra K, Kehrer JP (1991) Cyclophosphamide toxicity: characterising and avoiding the problem. Drugs 42:781–795

    Article  Google Scholar 

  4. West NJ (1997) Prevention and treatment of hemorrhagic cystitis. Pharmacother 17(4):696–706

    CAS  Google Scholar 

  5. Özcan A, Korkmaz A, Oter S, Coskun O (2005) Contribution of flavonoid antioxidants to the preventive effect of MESNA in cyclophosphamide-induced cystitis in rats. Arch Toxicol 79:461–465

    Article  PubMed  Google Scholar 

  6. Premila A, Indirani K, Preethi K (2008) Alterations in antioxidant enzyme activities and increased oxidative stress in cyclophosphamide-induced hemorrhagic cystitis in the rat. J Cancer Therapy 6:563–570

    Google Scholar 

  7. Virag L, Szabo E, Gergely P, Szabo C (2003) Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Let 141:113–124

    Article  Google Scholar 

  8. Das UB, Mallick M, Debnath JM, Ghosh D (2002) Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorders in male rats. Asian J Androl 4:201–207

    CAS  PubMed  Google Scholar 

  9. Manda K, Bhatia AI (2003) Prophylactic action of melatonin against Cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19:367–372

    Article  CAS  PubMed  Google Scholar 

  10. Mates JM, Perez-Gomez P, Nunez de Castro I (1999) Antioxidant enzymes and human disease. Clin Biochem 32:595–603

    Article  CAS  PubMed  Google Scholar 

  11. Cuzzocrea S, Reiter RJ (2001) Pharmacological action of melatonin in shock, inflammation, and ischemia/reperfusion injury. Eur J Pharmacol 426:1–10

    Article  CAS  PubMed  Google Scholar 

  12. Gouaze V, Mirault ME, Carpenter S, Salvayre R, Levade T, Andrieu-Abadie N (2001) Glutathione peroxidase-1 overexpression prevent ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 60:488–496

    CAS  PubMed  Google Scholar 

  13. Hoffmann PR, Berry MJ (2008) The influence of selenium on immune responses. Mol Nut Res 52:1273–1280

    Article  CAS  Google Scholar 

  14. Cao S, Durrani FA, Rustum YM (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clinical Cancer Research 10:2561–2569

    Article  CAS  PubMed  Google Scholar 

  15. Xu X, Malave A (2001) Protective effect of berberin on cyclophosphamide-induced hemorrhagic cystitis in rats. Pharmacol Toxicol 88:232–237

    Article  CAS  PubMed  Google Scholar 

  16. Abd-Allah ARA, Gado AM, Al-Majed A, Al-Yahya AA, Al-Shabanah OA (2004) Protective effect of taurine against cyclophosphamide-induced urinary bladder toxicity in rats. Clin and Exp Pharmacology and Physiology 31:167–172

    Google Scholar 

  17. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

    Article  CAS  PubMed  Google Scholar 

  18. Gray KJ, Engelmann UH, Fishman IJ (1986) Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol 133:497–500

    Google Scholar 

  19. Brock N, Pohl J, Stekar J (1981) Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 1. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer 17:595–601

    CAS  PubMed  Google Scholar 

  20. Korkmaz A, Topal T, Oter S (2007) Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23:303–312

    Article  CAS  PubMed  Google Scholar 

  21. Lundberg J (1996) Airbone nitric oxide: Inflammatory marker and aereocrine messenger in man. Acta Physiol Scand 157:1–27

    Article  Google Scholar 

  22. Ribeiro RA, Feritas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA (2002) Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. Jurol 167(5):2229–2234

    CAS  Google Scholar 

  23. Davis L, Kuttan G (2000) Effect of Withania somnifera on cyclophosphamide-induced urotoxicity. Cancer Letter 148:9–17

    Article  CAS  Google Scholar 

  24. Yuan M, Smith PB, Brundrett RB, Colvin M, Fenselau C (1991) Glutathione conjugation with phospharamide mustard and Cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab Dispos 19:625–629

    CAS  PubMed  Google Scholar 

  25. Lee IM (1999) Antioxidant vitamins in the prevention of cancer. Proc Assoc Am Physicians 111:10–15

    Article  CAS  PubMed  Google Scholar 

  26. Batista CK, Mota JM, Souza ML, Brito GA, Cunha FQ, Ribeiro RA (2007) Amifostine and glutathione prevent ifosfamide and acrolein-induced hemorrhagic cystitis. Cancer Chemother Pharmacol 59:71–77

    Article  CAS  PubMed  Google Scholar 

  27. Navarova J, Ujhazy E, Dubovicky M (1999) Protective effect of the antioxidant stobadineagainst Cyclophosphamide and irradiation induced oxidative stress. Gen Physiol Biophys 18:112–119

    CAS  PubMed  Google Scholar 

  28. Aruoma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251–255

    CAS  PubMed  Google Scholar 

  29. Whanger PD (1981) Selenium and heavy metal toxicity. JE, In Spallholz JL, Martin HE (eds), Ganther: Selenium in Biology and Medicine. AVI Westport Conn 230-255

  30. Diplock AT, Watkins WJ, Heurson M (1986) Selenium and heavy metals. Ann Clin Res 18:55–60

    CAS  PubMed  Google Scholar 

  31. Ip C (1986) Selenium and experimental cancer. Ann Clin Res 18:22–29

    CAS  PubMed  Google Scholar 

  32. Jamba L, Nehru B, Bansal MP (1997) Selenium Supplementation During Cadmium Exposure: Changes in Antioxidant Enzymes and the Ultrastructure of the Kidney. The Journal of Trace Elements in Experimental Medicine 10:233–242

    Article  CAS  Google Scholar 

  33. Furst A (2002) Can nutrition affect chemical toxicity? Int J Toxicol 21:419–424

    Article  CAS  PubMed  Google Scholar 

  34. Olas B, Wachowicz B (1997) Selenium in the cytotoxicity of cisplatin. Postepy Hyg Med Dos 51:95–108

    CAS  Google Scholar 

  35. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Viking-Bakker A, Zwinderman AH, Cleton FJ, Osanto S (2004) Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomized, double-blind, placebo-controlled study. Eur J Cancer 40:1713–1723

    Article  CAS  PubMed  Google Scholar 

  36. Zeng H, Combs GF (2008) Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. Journal of Nutritional Biochemistry 19:1–7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Arts and Science, Department of Biology, Meselik Campus, Izmir Osmangazi University, F5 26480, Eskisehir, Turkey

    Adnan Ayhanci, Suzan Yaman, Gokhan Bayramoglu, Hakan Senturk, Yilmaz Altuner & Sibel Gunes

  2. Department of Histology, Faculty of Medicine, Izmir Osmangazi University, Eskisehir, Turkey

    Varol Sahinturk

  3. Department of Physiology, Faculty of Medicine, Izmir Osmangazi University, Eskisehir, Turkey

    Ruhi Uyar

  4. Izmir Institute of Technology Department of Molecular Biology & Genetics, Biology & Genetics, Izmir Institute of Technology, Eskisehir, Turkey

    Sila Appak

Authors
  1. Adnan Ayhanci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzan Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Varol Sahinturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruhi Uyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gokhan Bayramoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hakan Senturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yilmaz Altuner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sila Appak
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sibel Gunes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adnan Ayhanci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayhanci, A., Yaman, S., Sahinturk, V. et al. Protective Effect of Seleno-l-Methionine on Cyclophosphamide-Induced Urinary Bladder Toxicity in Rats. Biol Trace Elem Res 134, 98–108 (2010). https://doi.org/10.1007/s12011-009-8458-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-009-8458-y

Keywords

Search

Navigation